                               SEQUENCE LISTING

<110> THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
 
<120> STRUCTURE-BASED PEPTIDE INHIBITORS OF P53 AGGREGATION AS A NEW 
      APPROACH TO CANCER THERAPEUTICS

<130> 58086-364665

<140>
<141>

<150> 61/821,157
<151> 2013-05-08

<160> 82    

<170> PatentIn version 3.5

<210> 1
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Leu, Tyr, Glu or Trp

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Arg or Lys

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Leu or Tyr

<400> 1
Xaa Thr Xaa Ile Thr Xaa Glu 
1               5           


<210> 2
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Ile Leu Thr Ile Ile Thr Leu 
1               5           


<210> 3
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Leu, Tyr, Glu or Trp

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Leu or Tyr

<400> 3
Xaa Thr Arg Ile Thr Xaa Glu 
1               5           


<210> 4
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Leu Thr Arg Ile Thr Leu Glu 
1               5           


<210> 5
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Tyr Thr Arg Ile Thr Leu Glu 
1               5           


<210> 6
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Glu Thr Arg Ile Thr Leu Glu 
1               5           


<210> 7
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Leu Thr Arg Ile Tyr Leu Glu 
1               5           


<210> 8
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Tyr Thr Arg Ile Tyr Leu Glu 
1               5           


<210> 9
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Trp Thr Arg Ile Thr Leu Glu 
1               5           


<210> 10
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Trp Thr Arg Ile Tyr Leu Glu 
1               5           


<210> 11
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Glu Thr Arg Ile Tyr Leu Glu 
1               5           


<210> 12
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Leu Thr Lys Ile Thr Leu Glu 
1               5           


<210> 13
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Tyr Thr Lys Ile Thr Leu Glu 
1               5           


<210> 14
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Trp Thr Lys Ile Thr Leu Glu 
1               5           


<210> 15
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Glu Thr Lys Ile Thr Leu Glu 
1               5           


<210> 16
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Leu Thr Lys Ile Tyr Leu Glu 
1               5           


<210> 17
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Tyr Thr Lys Ile Tyr Leu Glu 
1               5           


<210> 18
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Glu Thr Lys Ile Tyr Leu Glu 
1               5           


<210> 19
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> misc_feature
<222> (1)..(16)
<223> This region may encompass 1-16 'Arg' residues, wherein some
      positions may be absent

<220>
<221> MOD_RES
<222> (19)..(19)
<223> Leu, Tyr, Glu or Trp

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Arg or Lys

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Leu or Tyr

<400> 19
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10                  15      


Pro Ile Xaa Thr Xaa Ile Thr Xaa Glu 
            20                  25  


<210> 20
<211> 6
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: p53 
      peptide segment

<400> 20
Thr Ile Ile Thr Leu Glu 
1               5       


<210> 21
<211> 7
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: p53 
      peptide segment

<400> 21
Leu Thr Ile Ile Thr Leu Glu 
1               5           


<210> 22
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 22
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Ile Leu Thr Arg Ile 
1               5                   10                  15      


Thr Leu Glu 
            


<210> 23
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 23
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Ile Tyr Thr Arg Ile 
1               5                   10                  15      


Thr Leu Glu 
            


<210> 24
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 24
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Ile Glu Thr Arg Ile 
1               5                   10                  15      


Thr Leu Glu 
            


<210> 25
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 25
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Ile Leu Thr Arg Ile 
1               5                   10                  15      


Tyr Leu Glu 
            


<210> 26
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 26
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Ile Tyr Thr Arg Ile 
1               5                   10                  15      


Tyr Leu Glu 
            


<210> 27
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 27
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Ile Trp Thr Arg Ile 
1               5                   10                  15      


Thr Leu Glu 
            


<210> 28
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 28
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Ile Trp Thr Arg Ile 
1               5                   10                  15      


Tyr Leu Glu 
            


<210> 29
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 29
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Ile Glu Thr Arg Ile 
1               5                   10                  15      


Tyr Leu Glu 
            


<210> 30
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 30
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Ile Leu Thr Lys Ile 
1               5                   10                  15      


Thr Leu Glu 
            


<210> 31
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 31
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Ile Tyr Thr Lys Ile 
1               5                   10                  15      


Thr Leu Glu 
            


<210> 32
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 32
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Ile Trp Thr Lys Ile 
1               5                   10                  15      


Thr Leu Glu 
            


<210> 33
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 33
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Ile Glu Thr Lys Ile 
1               5                   10                  15      


Thr Leu Glu 
            


<210> 34
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 34
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Ile Leu Thr Lys Ile 
1               5                   10                  15      


Tyr Leu Glu 
            


<210> 35
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 35
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Ile Tyr Thr Lys Ile 
1               5                   10                  15      


Tyr Leu Glu 
            


<210> 36
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 36
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Ile Glu Thr Lys Ile 
1               5                   10                  15      


Tyr Leu Glu 
            


<210> 37
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 37
Leu His Arg Ile Tyr Leu Glu 
1               5           


<210> 38
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 38
Leu Tyr Ile Arg Ile Leu Arg 
1               5           


<210> 39
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> (Nme)Arg

<400> 39
Leu Thr Arg Ile Tyr Leu Glu 
1               5           


<210> 40
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (5)..(5)
<223> (Nme)Tyr

<400> 40
Leu Thr Arg Ile Tyr Leu Glu 
1               5           


<210> 41
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (6)..(6)
<223> (Nme)Leu

<400> 41
Leu Thr Arg Ile Tyr Leu Glu 
1               5           


<210> 42
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (4)..(4)
<223> (Nme)Ile

<400> 42
Leu Thr Arg Ile Tyr Leu Glu 
1               5           


<210> 43
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> misc_feature
<222> (1)..(16)
<223> This sequence may encompass 5-16 'Arg' residues,
      wherein some positions may be absent

<400> 43
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10                  15      


<210> 44
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> misc_feature
<222> (1)..(16)
<223> This sequence may encompass 5-16 'Lys' residues,
      wherein some positions may be absent

<400> 44
Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
1               5                   10                  15      


<210> 45
<211> 18
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: SynB1 
      peptide

<400> 45
Arg Gly Gly Arg Leu Ser Tyr Ser Arg Arg Arg Phe Ser Thr Ser Thr 
1               5                   10                  15      


Gly Arg 
        


<210> 46
<211> 10
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: SynB3 
      peptide

<400> 46
Arg Arg Leu Ser Tyr Ser Arg Arg Arg Phe 
1               5                   10  


<210> 47
<211> 16
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: Penetratin 
      peptide

<400> 47
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210> 48
<211> 16
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: PenArg 
      peptide

<400> 48
Arg Gln Ile Arg Ile Trp Phe Gln Asn Arg Arg Met Arg Trp Arg Arg 
1               5                   10                  15      


<210> 49
<211> 16
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: PenLys 
      peptide

<400> 49
Lys Gln Ile Lys Ile Trp Phe Gln Asn Lys Lys Met Lys Trp Lys Lys 
1               5                   10                  15      


<210> 50
<211> 13
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: TatP59W 
      peptide

<400> 50
Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Trp Gln 
1               5                   10              


<210> 51
<211> 13
<212> PRT
<213> Human immunodeficiency virus

<400> 51
Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln 
1               5                   10              


<210> 52
<211> 13
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: R9-Tat 
      peptide

<400> 52
Gly Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Pro Gln 
1               5                   10              


<210> 53
<211> 11
<212> PRT
<213> Human immunodeficiency virus

<400> 53
Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210> 54
<211> 19
<212> PRT
<213> Brome mosaic virus

<400> 54
Lys Met Thr Arg Ala Gln Arg Arg Ala Ala Ala Arg Arg Asn Arg Trp 
1               5                   10                  15      


Thr Ala Arg 
            


<210> 55
<211> 15
<212> PRT
<213> Feline herpes virus

<400> 55
Arg Arg Arg Arg Asn Arg Thr Arg Arg Asn Arg Arg Arg Val Arg 
1               5                   10                  15  


<210> 56
<211> 13
<212> PRT
<213> Human T-lymphotropic virus 2

<400> 56
Thr Arg Arg Gln Arg Thr Arg Arg Ala Arg Arg Asn Arg 
1               5                   10              


<210> 57
<211> 17
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: P22 N-(14-30)
      peptide

<400> 57
Asn Ala Lys Thr Arg Arg His Glu Arg Arg Arg Lys Leu Ala Ile Glu 
1               5                   10                  15      


Arg 
    


<210> 58
<211> 18
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: pVEC 
      peptide

<400> 58
Leu Leu Ile Ile Leu Arg Arg Arg Ile Arg Lys Gln Ala His Ala His 
1               5                   10                  15      


Ser Lys 
        


<210> 59
<211> 27
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: Transportan 
      peptide

<400> 59
Gly Trp Thr Leu Asn Ser Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu 
1               5                   10                  15      


Lys Ala Leu Ala Ala Leu Ala Lys Lys Ile Leu 
            20                  25          


<210> 60
<211> 21
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: TP10 
      peptide

<400> 60
Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu Lys Ala Leu Ala Ala Leu 
1               5                   10                  15      


Ala Lys Lys Ile Leu 
            20      


<210> 61
<211> 12
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: PTD-4 
      peptide

<400> 61
Pro Ile Arg Arg Arg Lys Lys Leu Arg Arg Leu Lys 
1               5                   10          


<210> 62
<211> 12
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: PTD-5
      peptide

<400> 62
Arg Arg Gln Arg Arg Thr Ser Lys Leu Met Lys Arg 
1               5                   10          


<210> 63
<211> 21
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: Pep-1
      peptide


<220>
<223> N-term Ac

<220>
<223> C-term cya

<400> 63
Lys Glu Thr Trp Trp Glu Thr Trp Trp Thr Glu Trp Ser Gln Pro Lys 
1               5                   10                  15      


Lys Lys Arg Lys Val 
            20      


<210> 64
<211> 21
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: Pep-2 
      peptide


<220>
<223> N-term Ac

<220>
<223> C-term cya

<400> 64
Lys Glu Thr Trp Phe Glu Thr Trp Phe Thr Glu Trp Ser Gln Pro Lys 
1               5                   10                  15      


Lys Lys Arg Lys Val 
            20      


<210> 65
<211> 15
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: Pep-3
      peptide


<220>
<223> N-term Ac

<220>
<223> C-term cya

<400> 65
Lys Trp Phe Glu Thr Trp Phe Thr Glu Trp Pro Lys Lys Arg Lys 
1               5                   10                  15  


<210> 66
<211> 22
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: E N(1-22)
      peptide

<400> 66
Met Asp Ala Gln Thr Arg Arg Arg Glu Arg Arg Ala Glu Lys Gln Ala 
1               5                   10                  15      


Gln Trp Lys Ala Ala Asn 
            20          


<210> 67
<211> 18
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: B 21 N-(12-29)
      peptide

<400> 67
Thr Ala Lys Thr Arg Tyr Lys Ala Arg Arg Ala Glu Leu Ile Ala Glu 
1               5                   10                  15      


Arg Arg 
        


<210> 68
<211> 12
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: U2AF(142-153)
      peptide

<400> 68
Ser Gln Met Thr Arg Gln Ala Arg Arg Leu Tyr Val 
1               5                   10          


<210> 69
<211> 16
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: PRP6(129-144)
      peptide

<400> 69
Thr Arg Arg Asn Lys Arg Asn Arg Ile Gln Glu Gln Leu Asn Arg Lys 
1               5                   10                  15      


<210> 70
<211> 17
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: MAP 
      peptide

<400> 70
Lys Leu Ala Leu Lys Leu Ala Leu Lys Leu Ala Leu Ala Leu Lys Leu 
1               5                   10                  15      


Ala 
    


<210> 71
<211> 27
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: SBP 
      peptide

<400> 71
Met Gly Leu Gly Leu His Leu Leu Val Leu Ala Ala Ala Leu Gln Gly 
1               5                   10                  15      


Ala Trp Ser Gln Pro Lys Lys Lys Arg Lys Val 
            20                  25          


<210> 72
<211> 27
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: FBP 
      peptide

<400> 72
Gly Ala Leu Phe Leu Gly Trp Leu Gly Ala Ala Gly Ser Thr Met Gly 
1               5                   10                  15      


Ala Trp Ser Gln Pro Lys Lys Lys Arg Lys Val 
            20                  25          


<210> 73
<211> 27
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: MPG 
      peptide


<220>
<223> N-term Ac

<220>
<223> C-term cya

<400> 73
Gly Ala Leu Phe Leu Gly Phe Leu Gly Ala Ala Gly Ser Thr Met Gly 
1               5                   10                  15      


Ala Trp Ser Gln Pro Lys Lys Lys Arg Lys Val 
            20                  25          


<210> 74
<211> 27
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: MPG(delta-NLS) 
      peptide


<220>
<223> N-term Ac

<220>
<223> C-term cya

<400> 74
Gly Ala Leu Phe Leu Gly Phe Leu Gly Ala Ala Gly Ser Thr Met Gly 
1               5                   10                  15      


Ala Trp Ser Gln Pro Lys Ser Lys Arg Lys Val 
            20                  25          


<210> 75
<211> 17
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: REV(34-50)
      peptide

<400> 75
Thr Arg Gln Ala Arg Arg Asn Arg Arg Arg Arg Trp Arg Glu Arg Gln 
1               5                   10                  15      


Arg 
    


<210> 76
<211> 23
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: ACPP 
      peptide


<220>
<221> misc_feature
<222> (10)..(11)
<223> Residues at these positions are non-consecutive and are
      separated by a non-disclosed protease cleavage site

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Any amino acid

<400> 76
Glu Glu Glu Glu Glu Asp Asp Asp Asp Lys Ala Xaa Arg Arg Arg Arg 
1               5                   10                  15      


Arg Arg Arg Arg Arg Xaa Cys 
            20              


<210> 77
<211> 22
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: ACPP 
      peptide


<220>
<221> misc_feature
<222> (10)..(11)
<223> Residues at these positions are non-consecutive and are
      separated by a non-disclosed protease cleavage site

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Any amino acid

<400> 77
Glu Glu Glu Glu Glu Asp Asp Asp Asp Lys Ala Arg Arg Arg Arg Arg 
1               5                   10                  15      


Arg Arg Arg Arg Xaa Cys 
            20          


<210> 78
<211> 19
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: ACPP 
      peptide


<220>
<221> misc_feature
<222> (6)..(7)
<223> Residues at these positions are non-consecutive and are
      separated by a non-disclosed protease cleavage site

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Any amino acid

<400> 78
Glu Asp Asp Asp Asp Lys Ala Xaa Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10                  15      


Arg Xaa Cys 
            


<210> 79
<211> 23
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: ACPP 
      peptide


<220>
<221> misc_feature
<222> (7)..(8)
<223> Residues at these positions are non-consecutive and are
      separated by a non-disclosed protease cleavage site

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (19)..(19)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Any amino acid

<400> 79
Glu Glu Asp Asp Asp Asp Lys Ala Arg Xaa Arg Arg Xaa Arg Arg Xaa 
1               5                   10                  15      


Arg Arg Xaa Arg Arg Xaa Cys 
            20              


<210> 80
<211> 19
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: ACPP 
      peptide


<220>
<221> misc_feature
<222> (7)..(8)
<223> Residues at these positions are non-consecutive and are
      separated by a non-disclosed protease cleavage site

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Any amino acid

<400> 80
Asp Asp Asp Asp Asp Asp Lys Ala Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10                  15      


Arg Xaa Cys 
            


<210> 81
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 81
Gly Gly Met Asn Arg Arg Pro Ile 
1               5               


<210> 82
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 82
Ile Phe Leu Leu Trp Gln Arg 
1               5           


